Research workbench
Type IV secretion system effector protein bepa
Analyse Type IV secretion system effector protein bepa in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 2VY3
- Type
- protein
- Length
- 582 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Cell filamentation protein
- UniProt
- Q6G2A9
- Ligands
- NI, CL
- Pockets
- 9 · best druggability 0.65
Structure
x-ray diffraction · 1 distinct chain · 46% helix, 13% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Cell filamentation protein | protein | 291 | 46% helix, 13% strand | Q6G2A9 |
Ligands and binding sites
- NI · Nickel (II) ion · metal · 4 copies · chains A, B
- CL · Chloride ion · ion · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
9 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 238 | 0.65 | 0.83 | 34 | empty |
| 2 | 303 | 0.65 | 0.81 | 35 | empty |
| 3 | 558 | 0.63 | 0.75 | 55 | CL |
| 4 | 579 | 0.63 | 0.75 | 46 | CL |
| 5 | 104 | 0.41 | 0.76 | 18 | empty |
Interfaces
1 interface between chains.
- A–B · 639 Ų buried · 11 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 18 modified (engineered).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q6G2A9
- Elsewhere: RCSB PDB 2VY3 · PDBe 2VY3 · UniProt Q6G2A9
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.